Circulating adiponectin levels differ between patients with multiple myeloma and its precursor disease

OBJECTIVE: An increased risk of multiple myeloma (MM) has been observed among individuals with low pre-diagnostic circulating levels of adiponectin, a metabolic hormone that is typically underexpressed among those who are overweight or obese. To assess whether adiponectin may influence myeloma devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmann, Jonathan N, Mailankody, Sham, Korde, Neha, Wang, Ye, Tageja, Nishant, Costello, Rene, Zingone, Adriana, Hultcrantz, Malin, Pollak, Michael N, Purdue, Mark P, Landgren, Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611818/
https://www.ncbi.nlm.nih.gov/pubmed/28602036
http://dx.doi.org/10.1002/oby.21894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611818/
https://www.ncbi.nlm.nih.gov/pubmed/28602036
http://dx.doi.org/10.1002/oby.21894

Ejemplares similares